Article | May 13, 2025

Europe Has A Platform For Driving More Flexible Clinical Trials: It's Time To Use It

Source: DIA

By Katarina Nedog, European Federation of Pharmaceutical Industries and Associations (EFPIA)

GettyImages-1416816620 medical records, RWE

Europe's standing in the global landscape of clinical research is facing a significant downturn. Despite an overall surge in commercial trials worldwide, the European Economic Area has witnessed a concerning decline in its share over the last decade. This shift translates to tens of thousands fewer patients gaining access to crucial trials within Europe. Recent data paint a clear picture of a research system grappling with slowness and fragmentation. However, a collective commitment exists to revitalize Europe's potential as a prime location for clinical studies. Turning this commitment into tangible results is now paramount. Discover the challenges and the collaborative efforts underway to reverse this trend.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader